These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35956779)

  • 1. Aliskiren Hemifumarate Proliposomes for Improved Oral Drug Delivery: Formulation Development, In Vitro and In Vivo Permeability Testing.
    Kunamaneni P; Kovvasu S; Yeung S; Wang J; Shah S; Betageri G
    Molecules; 2022 Jul; 27(15):. PubMed ID: 35956779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of proliposomes and self micro-emulsifying drug delivery system for improved oral bioavailability of nisoldipine.
    Nekkanti V; Rueda J; Wang Z; Betageri GV
    Int J Pharm; 2016 May; 505(1-2):79-88. PubMed ID: 27041124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, Characterization, and In Vivo Pharmacokinetics of Tacrolimus Proliposomes.
    Nekkanti V; Rueda J; Wang Z; Betageri GV
    AAPS PharmSciTech; 2016 Oct; 17(5):1019-29. PubMed ID: 26729532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic Evaluation of Improved Oral Bioavailability of Valsartan: Proliposomes Versus Self-Nanoemulsifying Drug Delivery System.
    Nekkanti V; Wang Z; Betageri GV
    AAPS PharmSciTech; 2016 Aug; 17(4):851-62. PubMed ID: 26381913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliposomes of exemestane for improved oral delivery: formulation and in vitro evaluation using PAMPA, Caco-2 and rat intestine.
    Hiremath PS; Soppimath KS; Betageri GV
    Int J Pharm; 2009 Oct; 380(1-2):96-104. PubMed ID: 19616608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daptomycin Proliposomes for Oral Delivery: Formulation, Characterization, and In Vivo Pharmacokinetics.
    Arregui JR; Kovvasu SP; Betageri GV
    AAPS PharmSciTech; 2018 May; 19(4):1802-1809. PubMed ID: 29616488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation of Dronedarone Hydrochloride-Loaded Proliposomes: In Vitro and In Vivo Evaluation Using Caco-2 and Rat Model.
    Kovvasu SP; Kunamaneni P; Yeung S; Rueda J; Betageri GV
    AAPS PharmSciTech; 2019 Jun; 20(6):226. PubMed ID: 31214813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved oral bioavailability of valsartan using proliposomes: design, characterization and in vivo pharmacokinetics.
    Nekkanti V; Venkatesan N; Wang Z; Betageri GV
    Drug Dev Ind Pharm; 2015; 41(12):2077-88. PubMed ID: 26289004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliposomes as a drug delivery system to decrease the hepatic first-pass metabolism: case study using a model drug.
    Yanamandra S; Venkatesan N; Kadajji VG; Wang Z; Issar M; Betageri GV
    Eur J Pharm Sci; 2014 Nov; 64():26-36. PubMed ID: 25159836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and evaluation of celecoxib-loaded proliposomes with high lipid content.
    Jeon D; Kim KT; Baek MJ; Kim DH; Lee JY; Kim DD
    Eur J Pharm Biopharm; 2019 Aug; 141():139-148. PubMed ID: 31150807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of novel proliposome formulation for antioxidant peptide, glutathione with enhanced oral bioavailability and stability.
    Byeon JC; Lee SE; Kim TH; Ahn JB; Kim DH; Choi JS; Park JS
    Drug Deliv; 2019 Dec; 26(1):216-225. PubMed ID: 30843439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The preparation of Cistanche phenylethanoid glycosides liquid proliposomes: Optimized formulation, characterization and proliposome dripping pills in vitro and in vivo evaluation.
    Li M; Li Y; Liu W; Li R; Qin C; Liu N; Han J
    Eur J Pharm Sci; 2016 Oct; 93():224-32. PubMed ID: 27493021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimized preparation of vinpocetine proliposomes by a novel method and in vivo evaluation of its pharmacokinetics in New Zealand rabbits.
    Xu H; He L; Nie S; Guan J; Zhang X; Yang X; Pan W
    J Control Release; 2009 Nov; 140(1):61-8. PubMed ID: 19651165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliposome powders for enhanced intestinal absorption and bioavailability of raloxifene hydrochloride: effect of surface charge.
    Velpula A; Jukanti R; Janga KY; Sunkavalli S; Bandari S; Kandadi P; Veerareddy PR
    Drug Dev Ind Pharm; 2013 Dec; 39(12):1895-906. PubMed ID: 22458264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and in vivo evaluation of functionalized ritonavir proliposomes for lymphatic targeting.
    Ahammed V; Narayan R; Paul J; Nayak Y; Roy B; Shavi GV; Nayak UY
    Life Sci; 2017 Aug; 183():11-20. PubMed ID: 28647214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization, Optimization, In Vitro and In Vivo Evaluation of Simvastatin Proliposomes, as a Drug Delivery.
    Rahamathulla M; H V G; Veerapu G; Hani U; Alhamhoom Y; Alqahtani A; Moin A
    AAPS PharmSciTech; 2020 May; 21(4):129. PubMed ID: 32405982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oleic acid derivative of polyethylenimine-functionalized proliposomes for enhancing oral bioavailability of extract of Ginkgo biloba.
    Zheng B; Yang S; Fan C; Bi Y; Du L; Zhao L; Lee RJ; Teng L; Teng L; Xie J
    Drug Deliv; 2016 May; 23(4):1194-203. PubMed ID: 26635185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability enhancement of zaleplon via proliposomes: Role of surface charge.
    Janga KY; Jukanti R; Velpula A; Sunkavalli S; Bandari S; Kandadi P; Veerareddy PR
    Eur J Pharm Biopharm; 2012 Feb; 80(2):347-57. PubMed ID: 22041602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved oral delivery of resveratrol using proliposomal formulation: investigation of various factors contributing to prolonged absorption of unmetabolized resveratrol.
    Basavaraj S; Betageri GV
    Expert Opin Drug Deliv; 2014 Apr; 11(4):493-503. PubMed ID: 24456117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced bioavailability of exemestane via proliposomes based transdermal delivery.
    Jukanti R; Sheela S; Bandari S; Veerareddy PR
    J Pharm Sci; 2011 Aug; 100(8):3208-3222. PubMed ID: 21404279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.